Evidence map›Paper›PMID 37589123›Full record

Observational studyJournal of the American Heart Association2023

Effect of Cardiopulmonary Bypass on SARS-CoV-2 Vaccination Antibody Levels.

Raymond J Strobel, Adishesh K Narahari, Evan P Rotar, Andrew M Young, Jeffrey Vergales, J Hunter Mehaffey, Nicholas R Teman, John A Kern, Leora T Yarboro, Irving L Kron and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Raymond J StrobelDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0002-3129-3980
Adishesh K NarahariSchool of Medicine University of Virginia Charlottesville VA USA.ORCID 0000-0002-8708-9161
Evan P RotarDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0003-0601-8765
Andrew M YoungDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0002-5068-1962
Jeffrey VergalesDivision of Pediatric Cardiology, Department of Pediatrics University of Virginia Charlottesville VA USA.ORCID 0000-0002-9839-7557
J Hunter MehaffeyDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0002-0612-7737
Nicholas R TemanDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0001-7711-6966
John A KernDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.
Leora T YarboroDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0003-2104-4961
Irving L KronDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0000-0002-0910-2957
Michael R NelsonDivision of Allergy and Clinical Immunology, Department of Medicine University of Virginia Charlottesville VA USA.ORCID 0000-0003-0839-1010
Mark RoeserDivision of Cardiac Surgery, Department of Surgery University of Virginia Charlottesville VA USA.ORCID 0009-0006-2189-2863
University of Virginia · US

Funding

Cardiovascular Surgery Training ProgramT32HL007849 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KRON, IRVING L., LAUBACH, VICTOR E · 1998 to 2025
$7.0M
Network for Cardiothoracic Surgical Investigations in Cardiovascular MedicineUM1HL088925 · NHLBI · UNIVERSITY OF VIRGINIA · PI BADHWAR, VINAY, KRON, IRVING L. · 2013 to 2025
$6.8M
NHLBI NIH HHS T32 HL007849NHLBI NIH HHS UM1 HL088925
6 · The paper itself

Abstract

Background Adults undergoing heart surgery are particularly vulnerable to respiratory complications, including COVID-19. Immunization can significantly reduce this risk; however, the effect of cardiopulmonary bypass (CPB) on immunization status is unknown. We sought to evaluate the effect of CPB on COVID-19 vaccination antibody concentration after cardiac surgery. Methods and Results This prospective observational clinical trial evaluated adult participants undergoing cardiac surgery requiring CPB at a single institution. All participants received a full primary COVID-19 vaccination series before CPB. SARS-CoV-2 spike protein-specific antibody concentrations were measured before CPB (pre-CPB measurement), 24 hours following CPB (postoperative day 1 measurement), and approximately 1 month following their procedure. Relationships between demographic or surgical variables and change in antibody concentration were assessed via linear regression. A total of 77 participants were enrolled in the study and underwent surgery. Among all participants, mean antibody concentration was significantly decreased on postoperative day 1, relative to pre-CPB levels (-2091 AU/mL,

Indexed as

COVID-19COVID-19 VaccinesAdultAntibodiesCardiopulmonary BypassHumansSARS-CoV-2Spike Glycoprotein, CoronavirusVaccinationAntibodiesCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2cardiac surgerycardiopulmonary bypasscoronavirus disease 2019

Identifiers

PMID37589123
PMCPMC10547352
OpenAlexW4385898516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.